Time to Abandon Kidney Biopsy to Diagnose Membranous Nephropathy?

doi:10.2215/CJN.11180821

Editorial

. 2021 Dec;16(12):1787-1789.

doi: 10.2215/CJN.11180821. Epub 2021 Nov 15.

Time to Abandon Kidney Biopsy to Diagnose Membranous Nephropathy?

Pierre Ronco^{1

2}, Emmanuelle Plaisier^{2

3}

Affiliations

¹ Department of Nephrology, Centre Hospitalier du Mans, Le Mans, France.
² Unité Mixte de Recherche S1155, Sorbonne Université and Institut National de la Santé et de la Recherche Médicale, Paris, France.
³ Department of Nephrology, Association pour l'Utilisation du Rein Artificiel Paris Plaisance, Paris, France.

PMID: 34782362
PMCID: PMC8729492
DOI: 10.2215/CJN.11180821

Editorial

Time to Abandon Kidney Biopsy to Diagnose Membranous Nephropathy?

Pierre Ronco et al. Clin J Am Soc Nephrol. 2021 Dec.

. 2021 Dec;16(12):1787-1789.

doi: 10.2215/CJN.11180821. Epub 2021 Nov 15.

Authors

Pierre Ronco^{1

2}, Emmanuelle Plaisier^{2

3}

Affiliations

¹ Department of Nephrology, Centre Hospitalier du Mans, Le Mans, France.
² Unité Mixte de Recherche S1155, Sorbonne Université and Institut National de la Santé et de la Recherche Médicale, Paris, France.
³ Department of Nephrology, Association pour l'Utilisation du Rein Artificiel Paris Plaisance, Paris, France.

PMID: 34782362
PMCID: PMC8729492
DOI: 10.2215/CJN.11180821

No abstract available

Keywords: glomerulosclerosis; membranous nephropathy; nephrology.

PubMed Disclaimer

Comment on

Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy: A Validation Study.
Bobart SA, Han H, Tehranian S, De Vriese AS, Roman JCL, Sethi S, Zand L, Andrades Gomez C, Giesen CD, Soler MJ, Bomback AS, Fervenza FC. Bobart SA, et al. Clin J Am Soc Nephrol. 2021 Dec;16(12):1833-1839. doi: 10.2215/CJN.05480421. Epub 2021 Nov 15. Clin J Am Soc Nephrol. 2021. PMID: 34782349 Free PMC article.

Cited by

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
He JW, Cui DF, Zhou XJ, Chen P, Li Y, Zhang X, Wang YN, Gan T, Liu LJ, Shi SF, Zhu L, Hou P, Lv JC, Zhang H. He JW, et al. Front Immunol. 2022 Mar 11;13:846323. doi: 10.3389/fimmu.2022.846323. eCollection 2022. Front Immunol. 2022. PMID: 35359934 Free PMC article.
Hemoglobin-associated CALR in proximal tubule cells can be used as a biomarker for idiopathic membranous nephropathy.
Pang S, Tan Q, Xie B, Feng B, Zhou R, Liu Z, Wei H, Huang Y, Jili M, Xie Y, Li S, Zhao B, Li W, Yang R. Pang S, et al. Front Med (Lausanne). 2025 Jun 11;12:1574852. doi: 10.3389/fmed.2025.1574852. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40568201 Free PMC article.
Noninvasive Diagnostic Strategies for Membranous Nephropathy in the Nephrotic Syndrome Study Network.
Zee J, Hogan JJ, Abdullah A, Liu L, Kiryluk K, Beck LH Jr. Zee J, et al. Clin J Am Soc Nephrol. 2025 May 1;20(5):697-705. doi: 10.2215/CJN.0000000671. Epub 2025 Feb 28. Clin J Am Soc Nephrol. 2025. PMID: 40019793

References

1. Beck LH Jr., Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 361: 11–21, 2009 - PMC - PubMed
1. Du Y, Li J, He F, Lv Y, Liu W, Wu P, Huang J, Wei S, Gao H: The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: A meta-analysis. PLoS One 9: e104936, 2014 - PMC - PubMed
1. Bobart SA, De Vriese AS, Pawar AS, Zand L, Sethi S, Giesen C, Lieske JC, Fervenza FC: Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. Kidney Int 95: 429–438, 2019 - PubMed
1. Bobart SA, Han H, Tehranian S, De Vriese AS, Roman JCL, Sethi S, Zand L, Andrades Gomez C, Giesen CD, Soler MJ, Bomback AS, Fervenza FC: Noninvasive diagnosis of PLA2R-associated membranous nephropathy: A validation study. Clin J Am Soc Nephrol 16: 1833–1839, 2021 - PMC - PubMed
1. Kidney Disease: Improving Global Outcomes (KDIGO) : Clinical practice guideline for the management of glomerular diseases. Kidney Int 2021, in press - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Beck LH Jr., Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 361: 11–21, 2009 - PMC - PubMed

[2] Beck LH Jr., Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 361: 11–21, 2009 - PMC - PubMed

[3] Du Y, Li J, He F, Lv Y, Liu W, Wu P, Huang J, Wei S, Gao H: The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: A meta-analysis. PLoS One 9: e104936, 2014 - PMC - PubMed

[4] Du Y, Li J, He F, Lv Y, Liu W, Wu P, Huang J, Wei S, Gao H: The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: A meta-analysis. PLoS One 9: e104936, 2014 - PMC - PubMed

[5] Bobart SA, De Vriese AS, Pawar AS, Zand L, Sethi S, Giesen C, Lieske JC, Fervenza FC: Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. Kidney Int 95: 429–438, 2019 - PubMed

[6] Bobart SA, De Vriese AS, Pawar AS, Zand L, Sethi S, Giesen C, Lieske JC, Fervenza FC: Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. Kidney Int 95: 429–438, 2019 - PubMed

[7] Bobart SA, Han H, Tehranian S, De Vriese AS, Roman JCL, Sethi S, Zand L, Andrades Gomez C, Giesen CD, Soler MJ, Bomback AS, Fervenza FC: Noninvasive diagnosis of PLA2R-associated membranous nephropathy: A validation study. Clin J Am Soc Nephrol 16: 1833–1839, 2021 - PMC - PubMed

[8] Bobart SA, Han H, Tehranian S, De Vriese AS, Roman JCL, Sethi S, Zand L, Andrades Gomez C, Giesen CD, Soler MJ, Bomback AS, Fervenza FC: Noninvasive diagnosis of PLA2R-associated membranous nephropathy: A validation study. Clin J Am Soc Nephrol 16: 1833–1839, 2021 - PMC - PubMed

[9] Kidney Disease: Improving Global Outcomes (KDIGO) : Clinical practice guideline for the management of glomerular diseases. Kidney Int 2021, in press - PubMed

[10] Kidney Disease: Improving Global Outcomes (KDIGO) : Clinical practice guideline for the management of glomerular diseases. Kidney Int 2021, in press - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Time to Abandon Kidney Biopsy to Diagnose Membranous Nephropathy?

Affiliations

Time to Abandon Kidney Biopsy to Diagnose Membranous Nephropathy?

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources